Literature DB >> 7578412

An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects.

R Haubrich1, J A McCutchan, R Holdredge, L Heiner, J Merritt, B Merchant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7578412     DOI： 10.1089/hum.1995.6.7-941

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  1 in total

Review 1.  Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Authors:  T M Clay; M C Custer; P J Spiess; M I Nishimura
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.